Summary of findings: colistimethate dry powder for inhalation (Colobreathe®) vs tobramycin
FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
- Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 374 participantsLow